Transsphenoidal surgery, a minimally invasive procedure to remove pituitary tumors through the nose, achieved long-term remission in nearly all children…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Limiting the number of measurements in the low-dose overnight dexamethasone suppression test (oDST), which is commonly used to diagnose…
Long-term use of topical corticosteroids for a genetic skin condition caused Cushing’s syndrome and adrenal insufficiency — low hormone production…
A combination of two noninvasive tests — the dexamethasone suppression test and high-resolution MRI scans — was found to correctly…
Korlym (mifepristone) lowered the levels of hemoglobin A1c (HbA1c), which reflects the average amount of blood sugar over the…
Surgery to remove pituitary tumors, the first-line treatment for Cushing’s disease, can increase the risk of venous thromboembolism (VTE),…
Surgeons used ultrasound to successfully remove a pituitary tumor that was undetectable by MRI to cure a 55-year-old woman of…
Most people with Cushing’s syndrome see their adrenal function recover after first-line surgery to remove disease-causing tumors, even though it…
Two women with Cushing’s disease successfully used the cortisol-lowering medication metyrapone during their pregnancy, a case study shows. “Metyrapone…
Treatment with Signifor (pasireotide) normalized urinary cortisol levels in about half of adults with Cushing’s disease, regardless of…